Supplementary MaterialsFigure S1: Bisulfite amplicon epigenetic CpG methylation target sites for FOXP3 TSDR, FOXP3 promoter, TBX21, RORC2, and TIGIT loci. It has been classically described as an autoimmune disease, mediated by pro-inflammatory Th1 and Th17 T-cell subsets. Studies suggest that…